H
Hiroyuki Mano
Researcher at University of Tokyo
Publications - 308
Citations - 24554
Hiroyuki Mano is an academic researcher from University of Tokyo. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 66, co-authored 275 publications receiving 22190 citations. Previous affiliations of Hiroyuki Mano include Astellas Pharma & Nagasaki University.
Papers
More filters
Journal ArticleDOI
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents
Yasuhiko Kano,Miyuki Akutsu,Saburo Tsunoda,Hiroyuki Mano,Yuko Sato,Yoshio Honma,Yusuke Furukawa +6 more
TL;DR: The present findings suggest that the simultaneous administration of STI571 with other agents except methotrexate would be advantageous for cytotoxic effects against Ph(+) leukemias and these combinations would be worthy of clinical trials.
Journal ArticleDOI
Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis
Eugene Berezikov,Geert van Tetering,Mark Verheul,Jose van de Belt,Linda W. van Laake,Joost B. Vos,R. E. Verloop,Marc van de Wetering,Victor Guryev,Shuji Takada,Anton Jan van Zonneveld,Hiroyuki Mano,Ronald H.A. Plasterk,Edwin Cuppen +13 more
TL;DR: This work discovered novel microRNA candidates using two approaches: testing of computationally predicted microRNAs by a modified microarray-based detection system and cloning and sequencing of large numbers of small RNAs from different human and mouse tissues.
Journal ArticleDOI
KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.
Yuki Togashi,Manabu Soda,Seiji Sakata,Emiko Sugawara,Emiko Sugawara,Satoko Hatano,Reimi Asaka,Takashi Nakajima,Hiroyuki Mano,Hiroyuki Mano,Kengo Takeuchi +10 more
TL;DR: KLC1-ALK is the first novel oncogenic fusion identified using only FFPE tissues, and this finding will broaden the potential value of archival FFPe tissues and provide further biological and clinical insights into ALK-positive lung cancer.
Journal ArticleDOI
Array-based genomic resequencing of human leukemia
Yoshihiro Yamashita,J Yuan,Isao Suetake,Hiromu Suzuki,Yuichi Ishikawa,Young Lim Choi,Young Lim Choi,Toshihide Ueno,Manabu Soda,Toru Hamada,Hidenori Haruta,Shuji Takada,Yasushi Miyazaki,Hitoshi Kiyoi,Etsuro Ito,Tomoki Naoe,M Tomonaga,Minoru Toyota,Shoji Tajima,Atsushi Iwama,Hiroyuki Mano,Hiroyuki Mano +21 more
TL;DR: The data have shown a unique profile of gene mutations in human leukemia, and a somatic change responsible for an Arg-to-His substitution at amino-acid position 882 of DNA methyltransferase 3A, which resulted in a loss ofDNA methylation activity of >50%.
Journal ArticleDOI
MCPIP1 Ribonuclease Antagonizes Dicer and Terminates MicroRNA Biogenesis through Precursor MicroRNA Degradation
Hiroshi I. Suzuki,Mayu Arase,Hironori Matsuyama,Young Lim Choi,Toshihide Ueno,Hiroyuki Mano,Hiroyuki Mano,Koichi Sugimoto,Kohei Miyazono +8 more
TL;DR: The presence of this abortive processing machinery and diversity of MCPIP1-related genes may imply a dynamic evolutional transition of the RNA silencing system, and suggest that the balance between processing and destroying ribonucleases modulates miRNA biogenesis and potentially affects pathological miRNA dysregulation.